The IP Lifecycle Of Medtech Innovation

We regularly hear about potential new medications, treatments and even possible cures for conditions across the medical spectrum, but only a small proportion of these ever actually make it to the market. Even where they do, this can take years from the first announcement. In order for a medical product to be brought to market, it of course must be subject to various rounds of clinical trials to confirm its efficacy, before being assessed for regulatory approval.

The IP lifecycle of a product can paint an interesting picture when viewed through the lens of advancing innovation. Patent protection in particular is likely to be sought long before a product is ready for launch, in order to protect that innovation, whilst trade marks will usually follow much closer to launch.